title: Ondansetron in the treatment of panic disorder.
authors.affiliation: Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY 10032, USA.
authors.forename: F R
authors.initials: FR
authors.lastname: Schneier
authors.forename: R
authors.initials: R
authors.lastname: Garfinkel
authors.forename: B
authors.initials: B
authors.lastname: Kennedy
authors.forename: R
authors.initials: R
authors.lastname: Campeas
authors.forename: B
authors.initials: B
authors.lastname: Fallon
authors.forename: R
authors.initials: R
authors.lastname: Marshall
authors.forename: L
authors.initials: L
authors.lastname: O'Donnell
authors.forename: T
authors.initials: T
authors.lastname: Hogan
authors.forename: M R
authors.initials: MR
authors.lastname: Liebowitz
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000379:Agoraphobia / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017294:Ondansetron / Q000009:adverse effects / Q000627:therapeutic use*; D016584:Panic Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D010555:Personality Inventory; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D010865:Pilot Projects; D016896:Treatment Outcome
chemical_list: D017294:Ondansetron